WWW.PHARMAORG.COM WWW.PHARMAORG.COM: Any drug you wish to know about


EURAX       

      Use Eurax to treat scabies or to reduce itching associated with certain conditions.

How Taken
Shake the lotion well before use. Apply a thin layer of the cream or lotion to all body parts from the neck down to the soles of your feet (scabies does not usually infect the head). Apply the medication to dry skin and rub it in well. Leave the medication on for 24 hours, then, without washing, apply a second dose. Thoroughly wash off the medication 48 hours after the last application.

Warnings/Precautions
Do not use more of this medication than is recommended. Do not take this medication by mouth. Avoid application to the mouth, nose, or eyes. Treat sexual and other close contacts who are also infected. To prevent reinfection, wash all clothing, hats, bed clothes, bed linens, hair brushes, and combs with a strong cleanser in hot water to remove any mites or eggs.

Missed Dose
Two doses of Eurax, 24 hours apart, are recommended. If the second dose is missed, retreatment may be necessary. Contact your doctor or pharmacist if you miss a dose.

Possible Side Effects
You are not likely to experience serious side effects. Stop using Eurax and seek emergency medical attention if you experience an allergic reaction (shortness of breath; closing of your throat; swelling of your lips, face, or tongue; or hives).

Searching for something else? No problem!

Search for anything:

Sleep Apnea May Herald Early Heart Disease.
         The snoring and constant awakenings of severe sleep apnea could provide an early indication of heart disease, researchers report. Brazilian researchers detected early hardening of the arteries in 42- to 44-year-old patients with severe obstructive sleep apnea, despite the absence of overt signs of cardiovascular disease. People with obstructive sleep apnea repeatedly stop breathing in their sleep as a result of partial or complete blockage of the upper airway. The vascular abnormalities detected by researchers correlated significantly with the severity of the patient's sleep apnea, noted lead researcher Dr. Luciano F. Drager of the Heart Institute at the University of Sao Paulo Medical School.
Main Page   Site Map